Hutchison China MediTech (HCM) Prices 4.4M ADS Offering at $25/ADS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
Go back to Hutchison China MediTech (HCM) Prices 4.4M ADS Offering at $25/ADS
January 22, 2020 5:42 AM EST
Hutchison China MediTech Limited (NASDAQ: HCM) announced today that it intends to offer US$110 million of American Depositary Shares ("ADSs"), each representing five ordinary shares, par value US$0.10 each of Chi-Med, on the Nasdaq Global Select Market ("Offering"). Chi-Med intends to grant the underwriters a 30-day option to purchase up to an aggregate of US$16.5 million of additional ADSs at the public... More
January 21, 2020 5:12 PM EST
Hutchison China MediTech (NASDAQ: HCM) disclosed:
We are offering US$110,000,000 of American depositary shares, or ADSs, representing of our ordinary shares, par value US$0.10 per share. Each ADS represents five ordinary shares.
Our ADSs are listed on the Nasdaq Global Select... More
January 21, 2020 5:57 AM EST
Hutchison China MediTech Limited (NASDAQ: HCM) today announces that the independent Data Monitoring Committee (IDMC) of the Phase III pivotal study of surufatinib in advanced neuroendocrine tumors pancreatic (SANET-p) has completed a pre-planned interim analysis. The IDMC recommended that the study stops early as the pre-defined primary endpoint of progression free survival (PFS) had already been met.
Following the early success of this study, Chi-Med now plans to arrange a pre-New Drug Application (NDA) meeting with the China National Medical... More
